- Scanmed
Description: Infraredx™ develops high-resolution intravascular imaging technologies aimed at conquering vascular disease.
Clarispro™ HD-IVUS Dualpro™ IVUS+ NIRS Makoto™ Imaging System GM-30 Inflation Device OKAY II® Y-Connector Clinical Evidence PROSPECT II & PROSPECT ABSORB Study LRP Study About Us Events News Education Webinar Sessions Educational Sessions IVUS App Resources See more. Know more. Heal more.
The YELLOW III Study (NCT04710368) demonstrated how 26 weeks of Evolocumab could reduce NIRS mxLCBI (-93.7) and IVUS PAV (-1.38%) in non culprit lesions in stable angina patients. View the study and watch Dr. Annapoorna Kini’s interview at the American College of Cardiology (ACC) 2023 Annual Scientific Sessions.
Delivering best-in-class vessel structure visualization
- Scanmed